.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
QuintilesIMS
Express Scripts
Colorcon
McKesson
Cipla
Accenture
McKinsey
Federal Trade Commission
Boehringer Ingelheim

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020863

« Back to Dashboard

NDA 020863 describes PLETAL, which is a drug marketed by Otsuka and is included in one NDA. Additional details are available on the PLETAL profile page.

The generic ingredient in PLETAL is cilostazol. There are twelve drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cilostazol profile page.

Summary for 020863

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jan 15, 1999TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jan 15, 1999TE:RLD:Yes

Expired Orange Book Patents for NDA: 020863

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
OtsukaPLETALcilostazolTABLET;ORAL020863-001Jan 15, 1999► Subscribe► Subscribe
OtsukaPLETALcilostazolTABLET;ORAL020863-002Jan 15, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Cerilliant
Novartis
Mallinckrodt
Medtronic
Chinese Patent Office
Covington
Deloitte
Harvard Business School
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot